Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Sales (2019 - 2025)

Eton Pharmaceuticals' Return on Sales history spans 7 years, with the latest figure at 0.05% for Q3 2025.

  • For Q3 2025, Return on Sales fell 11.0% year-over-year to 0.05%; the TTM value through Sep 2025 reached 0.1%, changed 0.0%, while the annual FY2024 figure was 0.1%, 7.0% down from the prior year.
  • Return on Sales for Q3 2025 was 0.05% at Eton Pharmaceuticals, up from 0.14% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.43% in Q1 2021 and bottomed at 7.86% in Q3 2021.
  • The 5-year median for Return on Sales is 0.1% (2024), against an average of 0.71%.
  • The largest YoY upside for Return on Sales was 23584bps in 2021 against a maximum downside of -256216bps in 2021.
  • A 5-year view of Return on Sales shows it stood at 0.17% in 2021, then plummeted by -37bps to 0.11% in 2022, then tumbled by -171bps to 0.08% in 2023, then skyrocketed by 32bps to 0.05% in 2024, then increased by 2bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for ETON's Return on Sales are 0.05% (Q3 2025), 0.14% (Q2 2025), and 1.05% (Q1 2025).